Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SWX/PPGN stock hub

SWX/PPGN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/PPGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/PPGN

In the news

Latest news · SWX/PPGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E68.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-6.1

P25 n/aP50 n/aP75 n/a

ROIC2.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/PPGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

EUR

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	1,440
Employees Change	78%
Employees Change Percent	5.73
Enterprise value	CHF 1.4B
Exchange	SIX Swiss Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CH1110760852
Last refreshed	2026-05-10
Market cap	CHF 1.3B
Price	CHF 39.4
Price currency	CHF
Rev Per Employee	251,716.21x
Sector	Healthcare
Sic	8731
Symbol	swx/PPGN
Website	https://www.polypeptide.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.52%
EV Earnings	-69.14x
EV/EBIT	172.8x
EV/EBITDA	34.07x
EV/FCF	-48.39x
EV/Sales	3.76x
FCF yield	-2.17%
Forward P/E	68.89x
P/B ratio	4.1x
P/S ratio	3.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.18%
EBITDA Margin	9.79%
Gross margin	16.77%
Gross Profit	CHF 60.8M
Gross Profit Growth	57.25%
Gross Profit Growth Q	85.72%
Gross Profit Growth3 Y	55.99%
Gross Profit Growth5 Y	39.32%
Net Income	CHF -19.7M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-5.15%
Profit Margin	-5.44%
Profit Per Employee	CHF -13,687
ROA	0.67
Roa5y	1.37
ROCE	1.32
ROE	-6.07
Roe5y	-1.31
ROIC	2.08
Roic5y	3.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	102.77%
Cagr3y	15.09%
Cagr5y	-13.69%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	-13.3%
OCF Growth Q	-68.68%
OCF Growth10 Y	4.59%
OCF Growth3 Y	-3.13%
Revenue Growth	15.6x
Revenue Growth Q	10.15x
Revenue Growth Quarters	5x
Revenue Growth Years	3x
Revenue Growth3 Y	6.36x
Revenue Growth5 Y	6.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.49
Assets	CHF 769M
Cash	CHF 69.4M
Current Assets	CHF 297.7M
Current Liabilities	CHF 170.9M
Debt	CHF 131.6M
Debt EBITDA	CHF 3.29
Debt Equity	CHF 0.42
Debt FCF	CHF -4.67
Equity	CHF 317.1M
Interest Coverage	0.49
Liabilities	CHF 451.9M
Long Term Assets	CHF 471.3M
Long Term Liabilities	CHF 281M
Net Cash	CHF -62.2M
Net Cash By Market Cap	CHF -4.78
Net Debt EBITDA	CHF 1.75
Net Debt Equity	CHF 0.2
Tangible Book Value	CHF 304.2M
Tangible Book Value Per Share	CHF 9.21
WACC	9.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.74
Inventory Turnover	2.16
Net Working Capital	CHF 65.8M
Quick ratio	0.87
Working Capital	CHF 128.8M
Working Capital Turnover	CHF 2.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend per share	CHF 0
Last Dividend	CHF 0.3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	102.68%
200-day SMA	26.74
3Y total return	52.48%
50-day SMA	30.38
50-day SMA vs 200-day SMA	50over200
5Y total return	-52.1%
All Time High	147.4
All Time High Change	-73.27%
All Time High Date	2021-09-06
All Time Low	13.22
All Time Low Change	198.03%
All Time Low Date	2025-04-07
ATR	1.66
Beta	1.02
Beta1y	1.58
Beta2y	1.44
Ch YTD	50.96
High	41.7
High52	41.7
High52 Date	2026-05-08
High52ch	-5.52%
Low	39.4
Low52	18.2
Low52 Date	2025-05-21
Low52ch	116.48%
Ma50ch	29.68%
Price vs 200-day SMA	47.32%
RSI	69.85
RSI Monthly	62.32
RSI Weekly	75.02
Sharpe ratio	1.55x
Sortino ratio	2.84
Total Return	-0.09%
Tr YTD	50.96
Tr1m	32.44%
Tr1w	0.77%
Tr3m	53.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 7.9M
Operating Income Growth Q	235.4
Operating margin	2.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,958,106%
Net Borrowing	31,405,781.8
Shares Insiders	4.44%
Shares Institutions	10.29%
Shares Out	33,006,565
Shares Qo Q	-0.87%
Shares Yo Y	0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -30M
Average Volume	116,380.9x
Bv Per Share	9.61
CAPEX	CHF -100.3M
Ch1m	32.44
Ch1w	0.77
Ch1y	102.7
Ch3m	53.01
Ch3y	52.48
Ch5y	-52.27
Ch6m	68.74
Change	-3.31%
Change From Open	-2.96
Close	40.75
Days Gap	-0.37
Depreciation Amortization	27,146,081.8
Dollar Volume	2,590,550
Earnings Date	2026-08-13
EBIT	CHF 7.9M
EBITDA	CHF 35.5M
EPS	CHF -0.6
F Score	5
FCF	CHF -28.2M
FCF EV Yield	-2.07x
FCF Per Share	CHF -0.85
Financing CF	31,461,038
Fiscal Year End	December
Founded	1,952
Income Tax	CHF 1M
Investing CF	-104,004,279
Is Primary Listing	1
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Ma150	27.26
Ma150ch	44.51%
Ma20	36.77
Ma20ch	7.15%
Net CF	5,876,600
Next Earnings Date	2026-08-13
Open	40.6
P OCF Ratio	18.02
Position In Range	0
Ppne	420,375,314.3
Price Date	2026-05-08
Price EBITDA	CHF 36.66
Ptbv Ratio	4.28
Relative Volume	0.57x
Revenue	362,471,345x
SBC By Revenue	0.52x
Share Based Comp	1,882,523
Tax By Revenue	0.29x
Tr6m	68.74%
Volume	65,750
Z Score	1.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SWX/PPGN pay a dividend?

Capital-return profile for this ticker.

Performance

SWX/PPGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/PPGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.3%

Share of float held by funds and institutions

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

SWX/PPGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.8

Neutral momentum band

Price vs 200-day MA

+47.3%

50/200-day relationship not available

Beta (5Y)

1.02

Moves roughly with the market

Sharpe ratio

1.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/PPGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/PPGN stock rating?

swx/PPGN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/PPGN analysis?

The full report lives at /stocks/swx/PPGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/PPGN?

The latest report frames swx/PPGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/PPGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.